Genevieve Laforet

Genevieve Laforet

Company: Aspa Therapeutics

Job title: Vice President, Clinical Development


Complement-Mediated Thrombotic Microangiopathy Associated with Systemic AAV Gene Therapy 4:00 pm

• Review of the complement system and pathophysiology of thrombotic microangiopathy (TMA) • Learnings from the TMA experience in AAV gene therapy programs to date • Mechanistic hypotheses regarding TMA risk • Practical considerations around TMA surveillance, prophylaxis and managementRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.